Cognex (Tacrine)
Friday November 25, 2005
Just over a decade since its approval as a medication for Alzheimer's disease, Cognex begins to show its age and is now one of the least attractive treatment options. So why is Cognex out of favor?
Carrie Hill, PhD's Alzheimer's Disease Blog
From Carrie Hill, PhD, for About.com
Explore Alzheimer's Disease
Must Reads
About.com Special Features
Make Meals Easy
An easy way to put delicious meals together.Build Your Business
Get tips on starting up and staying competitive.Love Your Living Space
Achieve your dream home with advice from the pros.Financial Planning
Stay on top with our smart financial tips.
Also from About.com:
©2009 About.com, a part of The New York Times Company.
All rights reserved.
Comments
No comments yet. Leave a Comment